CFO Julie Brown left Smith & Nephew
Ms. Brown joined Smith & Nephew in February 2013. Ms. Brown is a Fellow of the Institute of Chartered Accountancy and Fellow of the Institute of Taxation.
She qualified with KPMG before working at ICI and AstraZeneca plc, where she served as Vice President Group Finance, and ultimately, as Interim Chief Financial Officer.
While at AstraZeneca, she undertook Commercial and Strategic roles and was Regional Vice President of Latin America, President of Portugal, and Vice President of Corporate Strategy and CFO R&D.
She has broad international experience, encompassing many areas of the healthcare value chain.
Ms. Brown has also led several multi-billion dollar cost saving and restructuring programmes in Commercial, Operations and R&D.
She is a member of the Board of Directors of Roche Holding Ltd and Chair of the Roche Audit Committee. She has also fulfilled two Non-Executive Directorships with the NHS in the UK and the British Embassy in Portugal.
Ms. Brown has a first class honours degree, BA in Social Sciences, from Warwick University and has studied the Advanced Management Programme at INSEAD, Paris. ■
LATEST MOVES FROM United Kingdom
- Oxford Immunotec appoints Richard Wenstrup as CMO
- GSK appoints Laurie Glimcher as director
- British American Tobacco adds three directors
- Arix Bioscience appoints Meghan FitzGerald as director
- Aberdeen Emerging Markets Investment appoints director
More inside POST
PVH Corp. Q1 income rises 6% Earnings